SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-049857
Filing Date
2018-08-06
Accepted
2018-08-06 17:09:11
Documents
69
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-15873_110q.htm 10-Q 1338826
2 EX-31.1 a18-15873_1ex31d1.htm EX-31.1 12817
3 EX-31.2 a18-15873_1ex31d2.htm EX-31.2 12304
4 EX-32.1 a18-15873_1ex32d1.htm EX-32.1 9644
  Complete submission text file 0001104659-18-049857.txt   5981732

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ntgn-20180630.xml EX-101.INS 1274112
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ntgn-20180630.xsd EX-101.SCH 52210
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ntgn-20180630_cal.xml EX-101.CAL 45176
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ntgn-20180630_def.xml EX-101.DEF 207642
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ntgn-20180630_lab.xml EX-101.LAB 450358
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ntgn-20180630_pre.xml EX-101.PRE 359745
Mailing Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139 617-337-4701
Neon Therapeutics, Inc. (Filer) CIK: 0001694187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38551 | Film No.: 18995507
SIC: 2836 Biological Products, (No Diagnostic Substances)